Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Pediatrics > Early ROP screening urged for extremely premature infants, study finds
  • Pediatrics

Early ROP screening urged for extremely premature infants, study finds

Ophthalmology 360

Extremely premature infants, particularly those born before 24 weeks’ gestational age, are at significantly higher risk for developing severe retinopathy of prematurity (ROP) early in their postnatal life, according to a study that underscores the importance of initiating ROP screening examinations well before 31 weeks’ postmenstrual age (PMA) to detect and manage ROP progression promptly.

The study, comparing outcomes between infants born at 24-30 weeks’ gestational age (GA) and those born before 24 weeks’ GA (N = 2061), found significant differences in the prevalence and progression of ROP. Infants born at less than 24 weeks’ GA were notably more likely to develop severe forms of ROP, including pre-plus and plus disease, and required treatment earlier compared to those born at 24-30 weeks’ GA.

The study found that 8 infants developed pre-plus or greater severity ROP before 31 weeks’ PMA, with the majority (6 out of 8) born before 24 weeks’ GA. In addition, 3 infants developed plus disease or required treatment before 31 weeks’ PMA, with the earliest case identified at 27 and 3/7 weeks.

The findings suggest a potential shift in current screening practices, urging early vigilance and monitoring for ROP in extremely premature infants to mitigate severe visual impairments later in life.

Reference
Souverein EA, Siegel BA, Siegel LM, et al. Initiation of retinopathy of prematurity screening examinations in extremely premature infants. J AAPOS. 2024;103956. doi: 10.1016/j.jaapos.2024.103956. Epub ahead of print. PMID: 38878959.

Share

Related Content

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Pediatrics

Virtual reality vision therapy shows modest improvement in children with intermittent exotropia

  • Practice Management

New review highlights urgent need to tackle adherence gaps in eye care throughout the patient life cycle

  • Myopia

Dietary patterns linked to myopia risk in children and adolescents

  • Pediatrics

Did you know this rare condition has ocular implications?

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon